{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.085","value":"0.177"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"description":"Assessed serum clearance of ACZ885.","dispersionType":"Standard Deviation","groups":[{"description":"ACZ885 150 mg subcutaneous injection or 2 mg/kg subcutaneous injection, depending on body weight, every 8 weeks.","id":"OG000","title":"ACZ885"}],"paramType":"MEAN","populationDescription":"Patients in Part I and Part II who received at least one dose of ACZ885.","reportingStatus":"POSTED","timeFrame":"48 weeks after study start","title":"Pharmacokinetics (CLD (L/d))","type":"SECONDARY","unitOfMeasure":"L/day"}